Pembrolizumab activity in recurrent high-grade gliomas with partial or complete loss of mismatch repair protein expression: A monocentric, observational and prospective pilot study

This article has no abstract
Epistemonikos ID: 9eda26ccbd8bebe89a068e8dc1f2e66bc7ce0891
First added on: Feb 12, 2025